Loboz Katarzyna K, Shenfield Gillian M
Department of Pharmacology, University of Sydney, NSW, Australia.
Br J Clin Pharmacol. 2005 Feb;59(2):239-43. doi: 10.1111/j.0306-5251.2004.2188.x.
Recent studies have identified the 'triple whammy' in which combinations of diuretics, nonsteroidal anti-inflammatory drugs (NSAIDs), ACE inhibitors (ACEI) and/or angiotensin receptor antagonists (ARA) may impair renal function.
We performed a cross-sectional study of patients admitted to a general medical ward of a teaching hospital. Age, sex, disease status and prior consumption of the 'target' drugs, diuretics, NSAIDs (including aspirin), ACEI and ARA were correlated with creatinine and creatinine clearance on admission.
Three hundred and one patients (48% male) were included, 135 were on no prior target drugs, 87 on one, 60 on two and 19 on three such drugs. There was a significant (P < 0.01) correlation between both creatinine and creatinine clearance with male sex, age and number of target drugs. Multivariate analysis confirmed these associations but did not support associations between renal function and heart failure or total number of diagnoses. Increasing doses of diuretics, possibly because in many cases this included two drugs, but not the other drugs, were significantly (P < 0.001) associated with impaired renal function. For the other three drug groups patients on doses of any drug at lower than the defined daily dose (DDD) did not have significantly different creatinine or creatinine clearance from those on doses at or above the DDD.
Taking two or more of the identified drugs was associated with significant renal impairment but did not correlate with heart failure or other diseases for which the drugs might have been prescribed. Care is necessary to balance the demonstrated advantages of these medications against the risk of inducing renal failure.
最近的研究发现了“三重打击”现象,即利尿剂、非甾体抗炎药(NSAIDs)、血管紧张素转换酶抑制剂(ACEI)和/或血管紧张素受体拮抗剂(ARA)联合使用可能损害肾功能。
我们对一家教学医院普通内科病房收治的患者进行了一项横断面研究。将年龄、性别、疾病状态以及之前使用“目标”药物(利尿剂、NSAIDs(包括阿司匹林)、ACEI和ARA)的情况与入院时的肌酐水平和肌酐清除率进行关联分析。
共纳入301例患者(48%为男性),其中135例之前未使用过目标药物,87例使用过一种,60例使用过两种,19例使用过三种此类药物。肌酐水平和肌酐清除率与男性性别、年龄以及目标药物数量之间均存在显著相关性(P < 0.01)。多变量分析证实了这些关联,但不支持肾功能与心力衰竭或诊断总数之间的关联。利尿剂剂量增加(可能是因为在许多情况下这包括两种药物,而其他药物不是)与肾功能受损显著相关(P < 0.001)。对于其他三组药物,服用低于限定日剂量(DDD)的任何药物的患者与服用达到或高于DDD剂量的患者相比,肌酐水平或肌酐清除率没有显著差异。
服用两种或更多种已确定的药物与显著的肾功能损害相关,但与心力衰竭或可能已开具这些药物治疗的其他疾病无关。必须谨慎权衡这些药物已证实的益处与诱发肾衰竭的风险。